跳至主要内容
临床试验/IRCT2013102715178N1
IRCT2013102715178N1已完成未知

Comparing the efficacy of Tadalafil versus Placebo on pulmonary artery systolic pressure and right ventricular function in patients with beta-thalassemia intermedia

Babol University of Medical Sciences, Research and Technology Assistance0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion criteria (All of the following) : age more than 15 years ; major beta thalassemia patients (significant anemia, Hb< 7 and transfusion dependent) or Intermedia beta thalassemia (milder anemia, Hb between 7 and 10 and usually not transfusion dependent) ; Pulmonary Arterial Hypertension or Right Ventricle Dysfunction. Pulmonary Arterial Hypertension : mean pulmonary arterial pressure more than 25 mmHg at rest or more than 30 mmHg in activity (measured by transthoracic echocardiography). Right ventricular dysfunction as increase in right ventricle end-diastolic dimension (base> 4cm, midpart> 3.5) or decrease in function and ejection fraction of right ventricle according to TAPSE index (lesser than 2cm) and S index (lesser than 11cm) measured by transthoracic echocardiography.
  • Exclusion criteria (One of the following) : age< 15 years ; using nitrates and alpha blockers (except Tamsulosin) at the time of study ; minor beta thalassemia patients

排除标准

  • 未提供

研究者

发起方
Babol University of Medical Sciences, Research and Technology Assistance

相似试验